| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Feb 2025 | 31 Jan 2025 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31 2024 Outcome of the Board Meeting dated February 07, 2025 (As per BSE Announcement Dated on 07/02/2025) | ||
| Board Meeting | 12 Nov 2024 | 29 Oct 2024 |
| Quarterly Results Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for quarter/half year ended September, 2024 (As Per BSE Announcement Dated on: 12/11/2024) | ||
| Board Meeting | 13 Aug 2024 | 3 Aug 2024 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30 2024 & other business with the permission of Chair. The Board of Directors in its meeting held today approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 ,2024 (As per BSE Announcement dated on 13/08/2024) | ||
| Board Meeting | 28 May 2024 | 18 May 2024 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Financial Statements (Standalone) of the Company for the fourth quarter and year ended as on March 31 2024 and to discuss any other matter with the permission of the Chair. Audited Financial Results for the quarter and Financial Year ended March 31, 2024 Appointment of Secretarial Auditor & Internal Auditor of the Company for the Financial Year 2024-2025 (As Per BSE Announcement Dated on 28.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
